Pfizer said on Wednesday Chief Financial Officer Frank D'Amelio, 63, would retire after nearly 15 years at the company.
During his tenure, Pfizer slimmed down its business through sales to focus on its newer, patent-protected portfolio of profitable drugs such as cancer treatment Ibrance.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: